Cargando…

Flow cytometry-based immunophenotypic analysis of primary systemic light chain amyloidosis

Using flow cytometry, the present study aimed to investigate the immunophenotypic characteristics of malignant plasma cells (PCs) in the bone marrow of patients with primary systemic light chain amyloidosis (AL) compared with the characteristics of patients with multiple myeloma (MM). Flow cytometri...

Descripción completa

Detalles Bibliográficos
Autores principales: Diao, Xiangwen, Li, Juan, Ouyang, Juan, Liu, Junru, Huang, Beihui, Chen, Meilan, Gu, Jingli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403371/
https://www.ncbi.nlm.nih.gov/pubmed/28454452
http://dx.doi.org/10.3892/ol.2017.5767
_version_ 1783231409928798208
author Diao, Xiangwen
Li, Juan
Ouyang, Juan
Liu, Junru
Huang, Beihui
Chen, Meilan
Gu, Jingli
author_facet Diao, Xiangwen
Li, Juan
Ouyang, Juan
Liu, Junru
Huang, Beihui
Chen, Meilan
Gu, Jingli
author_sort Diao, Xiangwen
collection PubMed
description Using flow cytometry, the present study aimed to investigate the immunophenotypic characteristics of malignant plasma cells (PCs) in the bone marrow of patients with primary systemic light chain amyloidosis (AL) compared with the characteristics of patients with multiple myeloma (MM). Flow cytometric results of 51 patients with AL and 150 patients with MM were reviewed. The proportion of total bone marrow PCs in the patients with AL was significantly lower than that in the patients with MM, 1.35% (0.3–9.5%) vs. 9.7% (0.4–75.7%); (P<0.001). The cells in 24/51 patients with AL comprised two distinct populations: Normal PCs and malignant PCs, whereas only 11/150 patients with MM exhibited two populations. Patients with AL exhibited an increased cluster of differentiation (CD)19 expression compared with patients with MM, 4.5% (0.1–80.9%) vs. 1.6% (0.1–33.6%; P<0.001) and reduced CD138, with 90.8% (30.4–99.9%) vs. 95.0% (40.7–100%; P=0.006) and CD56, with 61.0% (1.5–99.2%) vs. 98.3% (0.1–100%; P<0.001) expression in malignant PCs. Light chain restriction was identified in all patients with AL, and the proportion of λ light chain restriction was 72.5%. The immunophenotypic characteristics of patients with AL demonstrated by flow cytometry were different compared with the characteristics of patients with MM in the number and composition of plasma cells, and the intracellular and extracellular expression of antigens. These differences may be associated with a less malignant phenotype of clonal PCs in AL than MM.
format Online
Article
Text
id pubmed-5403371
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-54033712017-04-27 Flow cytometry-based immunophenotypic analysis of primary systemic light chain amyloidosis Diao, Xiangwen Li, Juan Ouyang, Juan Liu, Junru Huang, Beihui Chen, Meilan Gu, Jingli Oncol Lett Articles Using flow cytometry, the present study aimed to investigate the immunophenotypic characteristics of malignant plasma cells (PCs) in the bone marrow of patients with primary systemic light chain amyloidosis (AL) compared with the characteristics of patients with multiple myeloma (MM). Flow cytometric results of 51 patients with AL and 150 patients with MM were reviewed. The proportion of total bone marrow PCs in the patients with AL was significantly lower than that in the patients with MM, 1.35% (0.3–9.5%) vs. 9.7% (0.4–75.7%); (P<0.001). The cells in 24/51 patients with AL comprised two distinct populations: Normal PCs and malignant PCs, whereas only 11/150 patients with MM exhibited two populations. Patients with AL exhibited an increased cluster of differentiation (CD)19 expression compared with patients with MM, 4.5% (0.1–80.9%) vs. 1.6% (0.1–33.6%; P<0.001) and reduced CD138, with 90.8% (30.4–99.9%) vs. 95.0% (40.7–100%; P=0.006) and CD56, with 61.0% (1.5–99.2%) vs. 98.3% (0.1–100%; P<0.001) expression in malignant PCs. Light chain restriction was identified in all patients with AL, and the proportion of λ light chain restriction was 72.5%. The immunophenotypic characteristics of patients with AL demonstrated by flow cytometry were different compared with the characteristics of patients with MM in the number and composition of plasma cells, and the intracellular and extracellular expression of antigens. These differences may be associated with a less malignant phenotype of clonal PCs in AL than MM. D.A. Spandidos 2017-04 2017-02-22 /pmc/articles/PMC5403371/ /pubmed/28454452 http://dx.doi.org/10.3892/ol.2017.5767 Text en Copyright: © Diao et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Diao, Xiangwen
Li, Juan
Ouyang, Juan
Liu, Junru
Huang, Beihui
Chen, Meilan
Gu, Jingli
Flow cytometry-based immunophenotypic analysis of primary systemic light chain amyloidosis
title Flow cytometry-based immunophenotypic analysis of primary systemic light chain amyloidosis
title_full Flow cytometry-based immunophenotypic analysis of primary systemic light chain amyloidosis
title_fullStr Flow cytometry-based immunophenotypic analysis of primary systemic light chain amyloidosis
title_full_unstemmed Flow cytometry-based immunophenotypic analysis of primary systemic light chain amyloidosis
title_short Flow cytometry-based immunophenotypic analysis of primary systemic light chain amyloidosis
title_sort flow cytometry-based immunophenotypic analysis of primary systemic light chain amyloidosis
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403371/
https://www.ncbi.nlm.nih.gov/pubmed/28454452
http://dx.doi.org/10.3892/ol.2017.5767
work_keys_str_mv AT diaoxiangwen flowcytometrybasedimmunophenotypicanalysisofprimarysystemiclightchainamyloidosis
AT lijuan flowcytometrybasedimmunophenotypicanalysisofprimarysystemiclightchainamyloidosis
AT ouyangjuan flowcytometrybasedimmunophenotypicanalysisofprimarysystemiclightchainamyloidosis
AT liujunru flowcytometrybasedimmunophenotypicanalysisofprimarysystemiclightchainamyloidosis
AT huangbeihui flowcytometrybasedimmunophenotypicanalysisofprimarysystemiclightchainamyloidosis
AT chenmeilan flowcytometrybasedimmunophenotypicanalysisofprimarysystemiclightchainamyloidosis
AT gujingli flowcytometrybasedimmunophenotypicanalysisofprimarysystemiclightchainamyloidosis